As compared with the forthmentioned CARs targeting PD-1 without CD 3ζ signaling domain, CARPD-L1z efficiently lysed PD-L1 positive tumor cells with enhanced cytokine secretion in vitro, which further eliminated multiple types of tumors in xenograft (87). The gene discussed is PDCD1; the disease is neoplasm.